Literature DB >> 19783067

Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.

Y Wiener-Well1, B Rudensky, A M Yinnon, P Kopuit, Y Schlesinger, E Broide, T Lachish, D Raveh.   

Abstract

During a national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP) in Israel, we conducted a point prevalence survey to determine the extent of asymptomatic carriage. Subsequently, a retrospective case-control study was done, comparing carriers of CRKP with non-carriers, in order to detect risk factors for carriage. Oral, perianal and rectal swabs were obtained from all hospitalised eligible and consenting patients. Selective media for carbapenem-resistant Gram-negative bacteria were used and pulsed-field gel electrophoresis (PFGE) helped to determine clonal source. Culture was obtained from 298 patients. Sixteen (5.4%) were carriers of CRKP, with a higher carriage rate in medical and surgical wards. Only 18% of carriers were treated with any carbapenem prior to the survey. Five of the 16 carriers had a positive clinical specimen for CRKP, hence a clinical infection versus asymptomatic carriage ratio of 1:3. The rectum was the most sensitive site sampled, detecting 15/16 carriers, and the overall sensitivity of the method was 94% with a negative predictive value of 99.6%. In a multivariate analysis of risk factors for CRKP carriage, three variables were significantly related to carriage state: diaper use, longer duration of hospital stay and vancomycin use. PFGE demonstrated that all 16 isolates were identical, confirming clonal origin. A point prevalence survey performed at a single medical centre during an outbreak of CRKP demonstrated a carriage rate of 5.4%. The clonal origin of these isolates suggests that strict adherence to isolation procedure may contain this outbreak. Copyright (c) 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783067     DOI: 10.1016/j.jhin.2009.07.022

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  41 in total

1.  Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay.

Authors:  Fred C Tenover; Rafael Canton; JoAnn Kop; Ryan Chan; Jamie Ryan; Fred Weir; Patricia Ruiz-Garbajosa; Vincent LaBombardi; David H Persing
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

2.  Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48.

Authors:  H Solgi; F Badmasti; Z Aminzadeh; C G Giske; M Pourahmad; F Vaziri; S A Havaei; F Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

3.  Healthcare personnel intestinal colonization with multidrug-resistant organisms.

Authors:  B K Decker; A F Lau; J P Dekker; C D Spalding; N Sinaii; S Conlan; D K Henderson; J A Segre; K M Frank; T N Palmore
Journal:  Clin Microbiol Infect       Date:  2017-05-12       Impact factor: 8.067

Review 4.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.

Authors:  L Lapointe-Shaw; T Voruganti; P Kohler; H-H Thein; B Sander; A McGeer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-11       Impact factor: 3.267

6.  Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.

Authors:  Evonne T Curran; Jonathan A Otter
Journal:  J Infect Prev       Date:  2014-09

7.  Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.

Authors:  S Shilo; M V Assous; T Lachish; P Kopuit; T Bdolah-Abram; A M Yinnon; Y Wiener-Well
Journal:  Infection       Date:  2012-12-28       Impact factor: 3.553

8.  Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.

Authors:  Karrera Y Djoko; Maud E S Achard; Minh-Duy Phan; Alvin W Lo; Manfredi Miraula; Sasiprapa Prombhul; Steven J Hancock; Kate M Peters; Hanna E Sidjabat; Patrick N Harris; Nataša Mitić; Timothy R Walsh; Gregory J Anderson; William M Shafer; David L Paterson; Gerhard Schenk; Alastair G McEwan; Mark A Schembri
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 9.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.

Authors:  Evan S Snitkin; Adrian M Zelazny; Pamela J Thomas; Frida Stock; David K Henderson; Tara N Palmore; Julia A Segre
Journal:  Sci Transl Med       Date:  2012-08-22       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.